“…milestone-driven biotech with multiple $100 million+ growth stage financing in Berlin, Mannheim, Munich, and visible participation from institutional lenders such as the European Investment Bank, KfW, German Kreditanstalt für Wiederaufbau, and major German commercial banks, signalizing a selective normalization of growth stage venture capital rather than broad-based early-stage exuberance.…
